MUVON Therapeutics nominated as finalist for 2023 ZKB Pionierpreis
MUVON's team is very proud to be amongst the 12 finalists for the ZKB Pionierpreis in 2023! The recognition of the impact of our mission is highly appreciated and we are looking forward to the final pitching days in May.
The Pionierpreis has been awarded by the ZKB and the TECHNOPARK® Zürich foundation for 20 years and is seen as a leading innovation award for Swiss startups.
Link to the full list of nominees.